INOVIO Pharmaceuticals, Inc.: INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

Collaboration will evaluate INOVIO's INO-5412 (INO-5401 plus INO-9012) in combination with Akeso's cadonilimab as a potential treatment for glioblastoma (GBM), the most common and aggressive ...
Nature

Cancer blood tests are everywhere. Do they really work?

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Portable CRISPR-based test detects four STIs, including syphilis, in under an hour

Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...

AbbVie Inc. (ABBV) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsRoopal Thakkar - Executive VP of Research ...
Le Lézard

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

INOVIO , and Akeso, Inc. (9926.HK) ("Akeso") today announced that they have entered into a clinical trial collaboration and ...